Market Scoping
& Market Access


We apply our expertise in data science, epidemiology, and health economics and outcomes research (HEOR) to help our clients gain a clear understanding of the markets in which they intend to enter or expand. This includes market sizing and market share, but also dynamic factors, such as growth potential. Our knowledge of U.S. and global healthcare markets also supports preparation for market access globally, including strategic assessments of key market access opportunities and challenges, compiling of clinical and economic evidence, building economic models for regulatory submissions, and strategic engagement with health technology assessment (HTA) authorities.

Types Of Engagements

  • Development of global value dossiers
  • Preparing materials in advance of review by U.S. Institute for Clinical and Economic Review (ICER)
  • Preparing materials in advance of submission to UK National Institute for Health and Care Excellence (NICE)
  • Novel analysis of real-world data (RWD) to support HTA submissions
  • Supporting submissions and responses to HTA reviews
  • Survey research of payer key opinion leaders (KOLs)
  • Global model adaptation
  • Estimation of market size for medical devices, diagnostics, & pharmaceuticals
  • Systematic & comprehensive summaries of literature & evidence
  • Publications in peer-reviewed journals

Key Staff

  • Andrew Briggs, DPhil, MSc
  • John Schneider, PhD
  • Jacie Cooper, MS
  • Anthony LoSasso, PhD
  • Robert Ohsfeldt, PhD

Related Markets & Industries

  • Insurance & Third-Party Payers
  • Medical Services
  • Hospitals & Health Systems
  • Pharmaceuticals & Biotechnology
  • Medical Devices & Diagnostics
  • Private Equity & Venture Capital
  • Consumer Products
  • Public Health
  • Government

Related Publications

Related Issue Briefs